Real-World Study on Effectiveness of Insulin Glargine U300 After Oral Antidiabetic Drug Failure in Patients with Type 2 Diabetes in the Gulf Region-Reference-Cited by-同舟云学术

Real-World Study on Effectiveness of Insulin Glargine U300 After Oral Antidiabetic Drug Failure in Patients with Type 2 Diabetes in the Gulf Region

Published:2024-02-15 Issue:3 Volume:15 Page:691-704
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Khan Niaz E.,Al Shaikh AbdulRahman A. M.,Hassoun Ahmed A. K.,Hassan Amr M.,Salah Mona M.,Al Abdella Nabeela A.,Safarini Saher S. M.,Al Dahi Waleed A.,Akil Yasser A.^ORCID

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13300-024-01537-2.pdf

Reference26 articles.

1. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care. 2015;38(1):140–9.

2. Crowder A et al. Type 2 diabetes: sequencing therapies. Johns Hopkins Diabetes Guide. Johns Hopkins Guides (2021). www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547147/all/Type_2_Diabetes:_Sequencing_Therapies

3. American Diabetes Association. Standards of medical care in diabetes—2022 abridged for primary care providers. Clin Diabetes. 2022;40(1):10–38.

4. Bolli GB, Riddle MC, Bergenstal RM, et al. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (edition 3). Diabetes Obes Metab. 2015;17(4):386–94.

5. Ji L, Bi Y, Ye S, et al. Comparison of insulin glargine 300 U/ml versus glargine 100 U/ml on glycemic control and hypoglycemic events in East Asian patients with type 2 diabetes: a patient-level meta-analysis of phase 3 studies. Diabetes Res Clin Pract. 2021;176: 108848.